Purpose
to fund epidemiological and clinical endpoint definition studies in support of adjuvanted purified and inactivated vaccine development
Grantee
Division
Global Development
Date
NOVEMBER 2014
Region served
AMERICA,
ASIA
Committed amount
$6,000,000
Grant topic
Research and Learning Opportunities
Duration (months)
30
Grantee location
Rixensart, Antwerpen, Belgium
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.